Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A11GA01	REDOXON EFF.ORANGE	B	Ascorbic acid (vit C) - 1g	1g	Tablet, effervescent	366,869 L.L
C10BA03	PRAVAFEN	B	Pravastatin sodium - 40mg, Fenofibrate - 160mg		Capsule, hard	1,264,556 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	1,521,230 L.L
J07CA11	DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE	B	Diphteria Toxoid1 - ?25Lf (?30IU)/0.5ml, Tetanus toxoid1 - ?2.5Lf (?40IU)/0.5ml, Bordetella pertussis (Whole cell) - ?16OU (?4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ?10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ?1.25mg , 2 conjugated to tetanos toxoid carrier protein -		Injectable suspension	1,515,854 L.L
L01EK01	INLYTA	B	Axitinib - 5mg	5mg	Tablet, film coated	136,632,514 L.L
L04AA06	CELLCEPT	B	Mycophenolate mofetil - 250mg	250mg	Capsule	6,083,575 L.L
M01AE01	ALGIFAST PEDIATRIC	B	Ibuprofen Lysine - 20mg/ml	20mg/ml	Suspension	393,746 L.L
N02AA59	DOLOSPASMINE COMP	B	Codeine phosphate - 40 mg, Hexahydro-adipenine HCl - 50 mg, Propyphenazone - 500 mg		Suppository	267,489 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 10mg	10mg	Tablet, film coated	593,978 L.L
A03AB02	GLYCOPYRROLATE	B	Glycopyronium Bromide - 0.2mg/ml	0.2mg/ml	Injectable solution	7,238,185 L.L
C10BA04	CHOLIB	B	Fenofibrate - 145mg, Simvastatin - 20mg		Tablet, film coated	1,251,117 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	764,646 L.L
L01EK01	INLYTA	B	Axitinib - 1mg	1mg	Tablet, film coated	33,373,253 L.L
L04AA06	CELLCEPT	B	Mycophenolate mofetil - 500mg	500mg	Tablet	6,083,575 L.L
M01AE01	ADVIL LIQUI-GELS EXTRA STRENGTH	B	Ibuprofen - 400mg	400mg	Capsule	575,165 L.L
R01AB06	TRIOFAN	B	Xylometazoline HCl - 0.5mg/ml, Carbocysteine - 5mg/ml		Spray, solution	608,761 L.L
A03AB06	SPASMOMEN	B	Otilonium bromide - 40mg	40mg	Tablet, film coated	438,093 L.L
A11GB	CAL-C-VITA EFFERVESCENT	B	Vitamin B6 - 15mg, Vitamin D - 300IU, Calcium carbonate - 625mg, Ascorbic acid - 1000mg		Tablet, effervescent	494,534 L.L
C10BA04	CHOLIB	B	Fenofibrate - 145mg, Simvastatin - 40mg		Tablet, film coated	1,358,625 L.L
G04CB02	AVODART	B	Dutasteride - 0.5mg	0.5mg	Capsule	2,660,787 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	764,646 L.L
L01EL01	IMBRUVICA	B	Ibrutinib - 140mg	140mg	Tablet, film coated	194,761,420 L.L
N02AB03	DUROGESIC	B	Fentanyl - 16.8mg	100mcg/h	Patch	5,911,563 L.L
R01AB06	TRIOFAN	B	Xylometazoline HCl - 1mg/ml, Carbocysteine - 10mg/ml		Spray, solution	646,388 L.L
A11JC	CYSTINE B6 BAILLEUL	B	Pyridoxine HCl - 50mg, L-Cystine - 500mg		Tablet, coated	862,747 L.L
C09DA04	CO APROVEL	B	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	658,483 L.L
C10BA05	ATOZET	B	Atorvastatin - 10mg, Ezetimibe - 10mg		Tablet, film coated	1,624,706 L.L
L01AA06	HOLOXAN	B	Ifosfamide - 1g	1g	Injectable powder for solution	3,586,850 L.L
M01AE01	NEURALGINE EXTRA IBU-LYSINAT	B	Ibuprofen (DL Lysine) - 400mg (684mg)	684mg	Tablet, film coated	833,182 L.L
N02AB03	DUROGESIC	B	Fentanyl - 8.4mg	50mcg/h	Patch	3,019,614 L.L